Equity Capital Markets

All filings · since 4 November 2002

Filings

Every share-offering filing on EDGAR since the day foreign issuers also had to file electronically. One row per filer: a filing made by a parent and its subsidiaries appears once for each of them, as in SEC's own index.

Page 1 · newest first · 50 per pageDownload as CSV (up to 5,000 rows)
FiledCompanyFilingAccession
2024-05-23
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-24-001632
2024-05-23
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-24-001631
2023-11-08
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-23-000117
2023-11-06
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-23-000107
2023-08-16
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-23-002402
2023-05-11
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-23-000078
2023-05-09
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-23-001351
2023-04-28
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 S-3Shelf registered0001626199-23-000067
2022-09-21
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-22-000070
2022-09-20
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-22-000065
2021-11-19
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-21-004429
2021-11-10
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 S-3Shelf registered0001626199-21-000145
2021-07-02
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001626199-21-000090
2021-05-20
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-21-002049
2021-05-18
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-21-001985
2021-05-18
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-21-001983
2021-05-14
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 S-3Shelf registered0001626199-21-000068
2020-08-18
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-20-002196
2020-08-11
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 S-1Registration filed0001626199-20-000047
2020-07-16
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-20-001835
2020-07-08
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 S-3Shelf registered0001626199-20-000033
2019-04-04
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-19-000606
2019-03-18
ALPINE IMMUNE SCIENCES, INC.
Registered companyEffectiveCIK 1626199
 S-1Registration filed0001626199-19-000012
2018-06-11
ALPINE IMMUNE SCIENCES, INC.
ShelfEffectiveCIK 1626199
 424B5Shelf takedown0001193125-18-189391
2017-06-06
Nivalis Therapeutics, Inc.
CIK 1626199
 EFFECTDeclared effective9999999995-17-001464
2016-07-14
Nivalis Therapeutics, Inc.
ShelfEffectiveCIK 1626199
 EFFECTDeclared effective9999999995-16-005158
2016-07-06
Nivalis Therapeutics, Inc.
ShelfEffectiveCIK 1626199
 S-3Shelf registered0001047469-16-014162
2015-06-17
Nivalis Therapeutics, Inc.
IPOFinal prospectusCIK 1626199
 424B4Final prospectus0001047469-15-005528
2015-06-16
Nivalis Therapeutics, Inc.
IPOFinal prospectusCIK 1626199
 EFFECTDeclared effective9999999995-15-001635
2015-06-03
Nivalis Therapeutics, Inc.
IPOFinal prospectusCIK 1626199
 S-1/AAmendment0001047469-15-005190
2015-05-13
Nivalis Therapeutics, Inc.
IPOFinal prospectusCIK 1626199
 S-1Registration filed0001047469-15-004723
2015-02-13
Nivalis Therapeutics, Inc.
CIK 1626199
 DRSDraft made public0001410578-15-000070